Psoriasis epidemiology and demographics: Difference between revisions
Sapan Patel (talk | contribs) No edit summary |
Sapan Patel (talk | contribs) No edit summary |
||
| Line 4: | Line 4: | ||
Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Prevalence=== | |||
The [[prevalence]] of psoriasis in Western populations is estimated to be around 2-3%. | |||
===Age=== | ===Age=== | ||
| Line 13: | Line 15: | ||
===Developed Countries=== | ===Developed Countries=== | ||
A [[statistical survey|survey]] [http://www.psoriasis.org/files/pdfs/press/npfsurvey.pdf] conducted by the National Psoriasis Foundation (a US based psoriasis education and advocacy group, which is partly funded by [[pharmaceutical company|pharmaceutical companies]]) found a prevalence of 2.1% among adult Americans. The study also found that 35% of people with psoriasis could be classified as having moderate to severe psoriasis. | |||
==References== | ==References== | ||
Revision as of 19:23, 10 April 2013
|
Psoriasis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Psoriasis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Psoriasis epidemiology and demographics |
|
Risk calculators and risk factors for Psoriasis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Epidemiology and Demographics
Prevalence
The prevalence of psoriasis in Western populations is estimated to be around 2-3%.
Age
Onset before age 40 usually indicates a greater genetic susceptibility and a more severe or recurrent course of psoriasis.
Gender
Psoriasis affects both sexes equally and can occur at any age, although it most commonly appears for the first time between the ages of 15 and 25 years.
Developed Countries
A survey [2] conducted by the National Psoriasis Foundation (a US based psoriasis education and advocacy group, which is partly funded by pharmaceutical companies) found a prevalence of 2.1% among adult Americans. The study also found that 35% of people with psoriasis could be classified as having moderate to severe psoriasis.